10-Q: Owlet Reports Q3 2025 Profit Amid Revenue Growth, Addresses Going Concern

Owlet, Inc. reported a net income of $4.134 million for Q3 2025, driven by a 44.6% revenue increase, but continues to face substantial doubt about its ability to continue as a going concern.

Summary

• Achieved net income of $4.134 million for the three months ended September 30, 2025, a significant improvement from a net loss of $5.611 million in the prior year period.
• Revenues increased by 44.6% to $31.988 million for Q3 2025 and by 37.5% to $79.155 million for the nine months ended September 30, 2025, primarily due to higher sales of Dream Sock and Dream Duo products and growth in the Owlet360 subscription service.
• Gross margin for Q3 2025 decreased to 50.6% from 52.2% in Q3 2024, largely due to tariffs, but increased for the nine months ended September 30, 2025, to 51.7% from 49.2%.
• Operating expenses decreased by 8.5% to $14.984 million for Q3 2025, driven by the absence of intangible asset impairment charges and an insurance loss recovery.
• Net cash used in operating activities for the nine months ended September 30, 2025, was $10.340 million, an improvement from $14.215 million in the prior year.
• The company had an accumulated deficit of $298.683 million as of September 30, 2025, and $23.760 million in cash and cash equivalents.
• Substantial doubt exists about the company's ability to continue as a going concern within one year due to historical operating losses and negative cash flows.
• Successfully remediated a previously identified material weakness in internal control over financial reporting related to the completeness and accuracy of sales returns.
• Identified new material weaknesses in internal control over financial reporting, including an ineffective control environment, segregation of duties, accounting for inventory/accrued liabilities, debt/equity arrangements, statement of cash flows review, and IT general controls.
• Completed a public offering in October 2025, raising net proceeds of $32.109 million from the sale of 4,825,400 shares of common stock.
• Settled two class-action lawsuits (Section 10(b) and Section 14(a) Claims) in October 2025 for $3.500 million and $1.750 million, respectively, with $1.159 million of the latter covered by insurance.
• Preliminary approval was granted for a derivative lawsuit settlement, which includes corporate governance reforms and $675 thousand in attorneys' fees.

Sentiment

Score: 6

Explanation: The company shows significant operational improvements with a return to net income and strong revenue growth in Q3 2025, coupled with a successful post-period capital raise that addresses immediate liquidity concerns. However, the persistent 'going concern' warning and newly identified material weaknesses in internal controls indicate fundamental challenges that temper overall sentiment. The positive operational momentum is offset by ongoing financial stability and governance risks.

Positives

• Achieved net income of $4.134 million in Q3 2025, a significant turnaround from a net loss of $5.611 million in Q3 2024.
• Experienced strong revenue growth of 44.6% in Q3 2025 and 37.5% for the nine months ended September 30, 2025, driven by increased consumer demand for Dream Sock and Dream Duo products and growth in the Owlet360 subscription service.
• Improved gross margin for the nine months ended September 30, 2025, to 51.7% from 49.2% in the prior year, attributed to higher revenue, favorable product mix, and lower direct costs.
• Reduced general and administrative expenses by 35.9% in Q3 2025, partly due to the absence of impairment charges related to intangible assets and an insurance loss recovery of $1.159 million.
• Net cash used in operating activities decreased to $10.340 million for the nine months ended September 30, 2025, from $14.215 million in the prior year, indicating improved operational cash efficiency.
• Successfully completed a public offering in October 2025, raising $32.109 million in net proceeds, enhancing liquidity and supporting future operations.
• Remediated a previously identified material weakness in internal control over financial reporting related to the completeness and accuracy of sales returns.
• Maintained compliance with all covenants under the WTI Loan Facility and the ABL Line of Credit as of September 30, 2025.
• The ABL Line of Credit was amended to modify financial covenants, increase capital expenditure limits, and expand eligible accounts receivable, providing greater financial flexibility.

Negatives

• Continues to have an accumulated deficit of $298.683 million as of September 30, 2025, and a history of recurring operating losses (with the exception of Q3 2025).
• Substantial doubt about the ability to continue as a going concern within one year after the date of the financial statements' issuance, due to historical operating and cash flow results relative to obligations.
• Gross margin decreased in Q3 2025 to 50.6% from 52.2% in Q3 2024, primarily due to the adverse impact of tariffs.
• Interest expense significantly increased by 667.9% in Q3 2025 and 1018.6% for the nine months ended September 30, 2025, driven by new loan facilities and the absence of prior year gains.
• A common stock warrant liability adjustment resulted in a $23.800 million loss for the nine months ended September 30, 2025, compared to a $9.534 million gain in the prior year.
• Identified new material weaknesses in internal control over financial reporting, including an ineffective control environment, issues with segregation of duties, accounting for inventory/accrued liabilities, debt/equity arrangements, statement of cash flows review, and IT general controls.
• Relies on a limited number of retailers for a substantial portion of sales, with one customer accounting for 46% of net revenues for the nine months ended September 30, 2025.
• Relies on single manufacturers for the assembly of key products (Dream Sock, Smart Sock, BabySat, and Owlet Cam), posing supply chain risks.
• Tariffs (20% on Vietnam imports, 19% on Thailand imports) have adversely impacted cost of goods sold and gross margins.

Risks

• Limited operating history and a history of losses, with no assurance of sustained profitability.
• Inability to manage business growth effectively could materially and adversely affect operations.
• Governmental authorities or notified bodies may require marketing authorization for products, leading to regulatory enforcement actions, recalls, and harm to financial results.
• Reliance on Apple's App Store and Google Play Store for mobile application distribution.
• A substantial portion of sales comes from a limited number of retailers.
• Failure to obtain and maintain marketing authorizations or certifications from the FDA or foreign regulatory authorities for medical device products.
• Reliance on single manufacturers for key products (Dream Sock, Smart Sock, BabySat, and Owlet Cam) could lead to manufacturing problems, delays, or increased costs.
• Inability to obtain, maintain, or successfully enforce intellectual property rights could adversely affect the commercial value of products and competitive position.
• Business and operations may suffer from IT system failures, cyberattacks, or deficiencies in cybersecurity.
• Development, maintenance, and use of artificial intelligence technologies may not be beneficial, could result in poor product performance, damage reputation, or incur liability.
• Increases in tariffs, trade restrictions, or taxes on products could have an adverse impact on operations.
• Involvement in disputes and other legal or regulatory proceedings that, if adversely decided or settled, could materially and adversely affect business.
• Risk of product liability claims and potentially inadequate insurance coverage.
• Operations in international markets expose the company to additional business, political, regulatory, operational, financial, and economic risks.
• Success depends substantially on reputation and brand.
• Some products and services are in development or recently introduced and may not achieve market acceptance.
• Material weaknesses in internal control over financial reporting may result in material misstatements or impaired access to capital markets.
• Need to raise additional capital in the future, which may not be available on acceptable terms or at all, leading to significant dilution or operational modifications.
• Substantial doubt about the ability to continue as a going concern may materially and adversely affect the stock price and ability to obtain financing.
• Cash held in bank deposit accounts may exceed federally insured limits, posing a risk in the event of financial institution failure.
• Changes in tax laws, such as the One Big Beautiful Bill Act of 2025 (OBBBA), may impact future financial position and results of operations.

Future Outlook

The company intends to use the net proceeds from its October 2025 public offering to support continued commercialization, research and development, and for general corporate purposes. However, the company's ability to continue as a going concern is subject to generating sufficient future cash flows from operations and obtaining additional financing, which cannot be assured. Remediation measures for identified material weaknesses in internal control over financial reporting are ongoing and will result in future costs. The company is also evaluating the impact of the One Big Beautiful Bill Act of 2025 (OBBBA) tax legislation on its financial statements.

Management Comments

• Our mission is to empower parents with the right information at the right time, to give them more peace of mind and help them find more joy in the journey of parenting.
• We believe that every parent deserves peace of mind and the opportunity to feel their well-rested best.
• We also believe that every child deserves to live a long, happy, and healthy life, and we are working to develop products to help facilitate that belief.
• Management has concluded that the remediation measures related to the completeness and accuracy of sales returns have been designed, implemented, and operated effectively, remediating the previously identified material weakness as of September 30, 2025.
• Our management believes that the unaudited condensed consolidated financial statements included in this Report state fairly in all material respects our financial position, results of operations and cash flows for the periods presented.

Industry Context

The company operates in the digital parenting and infant health monitoring market, demonstrating growth in consumer demand for smart baby monitoring solutions like Dream Sock and Dream Duo. The successful launch and growth of the Owlet360 subscription service indicate a strategic move towards recurring revenue models, aligning with broader trends in consumer technology and health. However, the company faces industry-wide challenges such as tariffs, which are impacting gross margins and reflecting geopolitical and trade policy pressures on global supply chains and manufacturing costs for consumer electronics. Continued investment in R&D suggests a competitive landscape requiring ongoing product innovation.

Management Changes

Corporate Governance

Legal Proceedings

• Butala v. Owlet, Inc. and Cherian v. Owlet, Inc. (Consolidated Class Actions): Alleged violations of Section 10(b) and Section 14(a) of the Exchange Act regarding FDA classification of Smart Sock. Settled for $3.500 million (Section 10(b) Claims) and $1.750 million (Section 14(a) Claims), with $1.159 million of the latter covered by insurance. Preliminary approvals granted in September 2025, and claims fully settled in October 2025. Final fairness hearing scheduled for February 6, 2026.
• Janet Vargas, Derivatively on Behalf of Nominal Defendant Owlet, Inc. and Nathan Capleton, Derivatively on Behalf of Nominal Defendant Owlet, Inc. (Consolidated Derivative Actions): Asserted claims for violations of Section 14(a) of the Exchange Act and state law claims including breach of fiduciary duty, unjust enrichment, and waste of corporate assets. Preliminary approval of settlement granted on September 10, 2025. Settlement includes specific corporate governance reforms and an unopposed request for $675 thousand in attorneys' fees. Final fairness hearing scheduled for February 6, 2026, with payment expected in Q1 2026.

Related Party Transactions

• In September 2024, as partial consideration for the WTI Loan Facility, the company issued 750,000 shares of redeemable common stock to WTI Fund X, LLC and WTI Fund XI, LLC (WTI Funds). These shares contain an embedded redemption option exercisable by the WTI Funds.
• The SBG Private Placement Warrants, issued to Sandbridge Acquisition Holdings LLC, represent warrants to purchase 471,428 shares of common stock at $161.00 per share, resulting from the merger with Sandbridge Acquisition Corporation (SBG).

Stakeholder Impact

• Shareholders: Face potential dilution from recent and future equity offerings, but benefit from improved operational performance and a successful capital raise. The 'going concern' doubt and internal control weaknesses pose ongoing risks to share value. Corporate governance reforms from legal settlements aim to improve oversight.
• Employees: Benefit from higher compensation expenses due to increased headcount and bonus accruals. Stock-based compensation plans are in place, but potential cost reductions could impact employment if additional funding is not secured.
• Customers: Experience increased demand for Dream Sock and Dream Duo products and the growth of the Owlet360 subscription service. Tariffs could potentially affect product pricing or availability.
• Creditors: The company's WTI Loan Facility and ABL Line of Credit are in compliance with covenants, and the recent capital raise improves liquidity for debt servicing, reducing immediate credit risk.
• Suppliers: The company's reliance on single manufacturers for key products creates a concentration risk for suppliers, potentially impacting supply chain stability.

Next Steps

• Utilize net proceeds from the October 2025 public offering to support continued commercialization, research and development, and for general corporate purposes.
• Continue to implement and enhance remediation measures for identified material weaknesses in internal control over financial reporting, including hiring additional accounting and financial reporting personnel and implementing new policies and procedures.
• Evaluate the impacts of the One Big Beautiful Bill Act of 2025 (OBBBA) tax legislation on the company's financial statements.
• Attend final fairness hearings for the Butala class action settlements and the Vargas derivative action settlement, both scheduled for February 6, 2026.

Key Dates

Recommendation

While Owlet, Inc. has shown significant operational improvements, including a return to net income in Q3 2025 and strong revenue growth, and has successfully raised capital post-period, the persistent 'going concern' warning and newly identified material weaknesses in internal controls present substantial risks. The company has demonstrated a commitment to addressing its financial stability and governance issues, and the settlement of legal proceedings removes some overhang. However, until these fundamental challenges are fully resolved and sustained profitability and positive cash flow from operations are consistently demonstrated, the stock's risk profile remains elevated. A 'hold' recommendation allows investors to monitor the effectiveness of remediation efforts and the company's ability to execute its strategic plans amidst these uncertainties.

Keywords

Baby monitoring, Smart sock, Infant health, Digital parenting, Wearable technology, SEC filing, Quarterly report, Financial results, Going concern, Capital raise, Litigation, Internal controls, Tariffs, Owlet360, Dream Sock, Dream Duo, BabySat, Medical device, FDA